Meeting
2017 ASCO Annual Meeting
Interplay between immune infiltration and tumor progression and survival in non-small cell lung cancer: An analysis of institutional and public data.
Authors
Ali Jalali
The University of Texas MD Anderson Cancer Center, Houston, TX
Ali Jalali , Jing Wang , Won-Chul Lee , Jianhua Zhang , Chia Chin Wu , Don Lynn Gibbons , XiMing Tang , Neda Kalhor , Julie Izzo , Carmen Behrens , Frank V. Fossella , Anne S. Tsao , J. Jack Lee , Stephen Swisher , John Heymach , Andrew Futreal , Ignacio Ivan Wistuba , Roy S. Herbst , Vassiliki Papadimitrakopoulou , Jianjun Zhang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Citation
J Clin Oncol 35, 2017 (suppl; abstr 8538)
DOI
10.1200/JCO.2017.35.15_suppl.8538
Abstract #
8538
Poster Bd #
274
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Analysis of the prognostic value of the tumor immunologic profile in resectable NSCLC.
First Author: Marta Usó
Poster
2024 ASCO Annual Meeting
Multiplex analysis of the immune environment before and after neoadjuvant durvalumab as a prognostic factor in resectable non-small cell lung cancer (NSCLC) in the IFCT-1601 IONESCO phase 2 trial.
First Author: Diane Damotte
Poster
2024 ASCO Gastrointestinal Cancers Symposium
PD1 and CD39 expression on tumor infiltrating lymphocytes in patients with gastric cancer.
First Author: Takafumi Okayama
Poster
2021 ASCO Annual Meeting
Features in genomics and tumor immune microenvironment in NSCLC treated with neoadjuvant PD-1 blockade.
First Author: Shuhang Wang